Webinar

GLP-1 Medications + Bone Health

Name: GLP-1 Medications + Bone Health
Start: 2026-06-04T15:00:00-04:00
End: 2026-06-04T16:00:00-04:00
Location: Zoom

There are many benefits to medication induced weight loss on an individual’s overall health, however, there are also implications on bone and muscle health that need to be considered and managed.

Join us with Dr. Claudia Gagnon on June 4th as she speaks to how GLP-1 treatments are changing not only appetites but individual habits, the strategies needed to mitigate bone and muscle loss in the context of medical weight loss and nutrient and exercise recommendations.

Webinar Details

Date:
Thursday, June 4, 2026

Time:
3:00 pm – 4:00 pm ET

Registration for this event is now closed.

Presenter

Dr. Claudia Gagnon, MD FRCPC

Dr. Claudia Gagnon is an adult endocrinologist at CHU de Québec-Université Laval, full professor in the Department of Medicine at Université Laval, and researcher at CHU de Québec-Université Laval Research Centre.

A large part of her clinical practice focuses on the treatment of osteoporosis, metabolic bone diseases and disorders of phosphocalcic metabolism. Her main research interests are on the impact of obesity, diabetes, and bariatric surgery on bone health.

Dr. Gagnon is actively involved within the Osteoporosis Canada Scientific Advisory Council and in various provincial and national committees including Diabète Québec, Diabetes Canada, and INESSS. She has collaborated on the international guidelines on vitamin D supplementation after bariatric surgery and X-linked hypophosphatemic rickets.

Tracie Napoli

Director, Fund Development and MARCOM
Osteoporosis Canada